Sign Up Today and Learn More About Pinnacle Medicines Stock
Invest in or calculate the value of your shares in Pinnacle Medicines or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Pinnacle Medicines Stock
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
About Pinnacle Medicines Stock
Founded
2024
Headquarters
Doylestown, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Pinnacle Medicines Press Mentions
Stay in the know about the latest news on Pinnacle Medicines
Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics
medcitynews • Apr 06, 2026
Ambrosia's sweet $100m round, and other biofinancings
pharmaphorum • Apr 03, 2026
峰肽药业完成8900万美元B轮融资,专注于口服多肽疗法研发融资
news • Mar 31, 2026
Pinnacle Medicines, a pioneer in oral peptide drugs, announced the completion of an $89 million Series B financing round.
jixin • Mar 27, 2026
Pinnacle Medicines closes $89 million Series B financing
thepharmaletter • Mar 27, 2026
Pinnacle Medicines Management
Leadership team at Pinnacle Medicines
Board of director
Diyong Xu
Join now and verify your accreditation status to gain access to:
- Pinnacle Medicines Current Valuation
- Pinnacle Medicines Stock Price
- Pinnacle Medicines Management
- Available deals in Pinnacle Medicines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pinnacle Medicines Cap Table and Funding History by Share Class and Liquidity Preferences
- Pinnacle Medicines Revenue and Financials
- Pinnacle Medicines Highlights
- Pinnacle Medicines Business Model
- Pinnacle Medicines Risk Factors
- Pinnacle Medicines Research Report from SACRA Research
Trading Pinnacle Medicines Stock
How to invest in Pinnacle Medicines stock?
Accredited investors can buy pre-IPO stock in companies like Pinnacle Medicines through EquityZen funds. These investments are made available by existing Pinnacle Medicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Pinnacle Medicines stock?
Shareholders can sell their Pinnacle Medicines stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 55K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."